Synta Pharmaceuticals, Inc. (SNTA) Misses Q2 EPS by 11c
Tweet Send to a FriendGet Alerts SNTA Hot Sheet
Price: $7.33 -2.27%
EPS Growth %: -11.1%
Financial Fact:
General and administrative: 3.88M
Today's EPS Names:
RAVN, CAMT, HAST, More
EPS Growth %: -11.1%
Financial Fact:
General and administrative: 3.88M
Today's EPS Names:
RAVN, CAMT, HAST, More
Trade SNTA Now!
Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) reported Q2 EPS of ($0.30), $0.11 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $4.19 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Qihoo 360 Technology (QIHU) Reports In-Line Q1 EPS; Guides Q2 Sales
- Alvarion Ltd (ALVR) Narrows Q1 Loss
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
